Effects of adductor muscle stimulation on speech in abductor spasmodic dysphonia

被引:19
作者
Bidus, KA
Thomas, GR
Ludlow, CL
机构
[1] NINDS, Med Neurol Branch, Laryngeal & Speech Sect, NIH, Bethesda, MD 20892 USA
[2] Natl Inst Deafness & Other Commun Disorders, Tumor Biol Sect, NIH, Bethesda, MD USA
关键词
voice; muscle stimulation; spasmodic dysphonia;
D O I
10.1097/00005537-200011000-00033
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To determine whether adductor laryngeal muscle stimulation might be a beneficial treatment alternative for abductor spasmodic dysphonia (ABSD), Study Design: Baseline comparisons were made on measures of voiceless consonant and syllable duration between patients with ABSD and normal control subjects, and speech and voice production with and without muscle stimulation were compared within 10 patients with ABSD, Methods: Baseline group comparisons were conducted on measures of syllable and voiceless consonant duration between the patients and the control subjects. Neuromuscular stimulation was applied to the thyroarytenoid or lateral cricoarytenoid muscles in the patients during extended phonation, and measures were made of fundamental frequency and sound pressure level in the stimulated and nonstimulated conditions. Voiceless consonant duration was compared with and without adductor laryngeal muscle stimulation during syllable repetitions and sentences in the patients, Results: Before stimulation, the patients had increased syllable durations in comparison with control subjects (P = .003), Repeated within-patient comparisons with and without stimulation demonstrated significant (P < .008) reductions in voiceless consonant durations during syllable repetition. The more severely affected patients had the greatest reductions in voiceless consonant duration during sentence production. Conclusions: Adductor muscle stimulation improved speech production in patients with ABSD, and the improvement was greatest in the most severely affected patients. Therefore adductor muscle stimulation has potential for benefiting patients with ABSD.
引用
收藏
页码:1943 / 1949
页数:7
相关论文
共 23 条
  • [1] Effects of botulinum toxin on pathophysiology in spasmodic dysphonia
    Bielamowicz, S
    Ludlow, CL
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2000, 109 (02) : 194 - 203
  • [2] Botulinum toxin management of spasmodic dysphonia (Laryngeal dystonia): A 12-year experience in more than 900 patients
    Blitzer, A
    Brin, MF
    Stewart, CF
    [J]. LARYNGOSCOPE, 1998, 108 (10) : 1435 - 1441
  • [3] BLITZER A, 1988, LARYNGOSCOPE, V98, P193
  • [4] BLITZER A, 1992, LARYNGOSCOPE, V102, P163
  • [5] Broniatowski M, 1993, ASAIO J, V39, P24
  • [6] BRONIATOWSKI M, 1993, LARYNGOSCOPE, V103, P734
  • [7] CANNITO MP, 1996, DISORDERS MOTOR SPEE, P311
  • [8] FRIEDMAN M, 1994, LARYNGOSCOPE, V104, P1240
  • [9] IMPLANTATION OF A RECURRENT LARYNGEAL NERVE STIMULATOR FOR THE TREATMENT OF SPASTIC DYSPHONIA
    FRIEDMAN, M
    TORIUMI, DM
    GRYBAUSKAS, VT
    APPLEBAUM, EL
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1989, 98 (02) : 130 - 134
  • [10] TREATMENT OF SPASTIC DYSPHONIA WITHOUT NERVE-SECTION
    FRIEDMAN, M
    TORIUMI, DM
    GRYBAUSKAS, V
    APPLEBAUM, EL
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1987, 96 (05) : 590 - 596